Meet the
Expert Session
Want to learn more about our RESILIA valves portfolio?
We invite you to attend our live presentations at the booth with experts sharing their experiences with INSPIRIS and MITRIS RESILIA valves.
Thursday 10 Oct 2024
MITRIS RESILIA valve:The Latest Mitral Surgical Innovation
A Patient Story: Double Valve Replacement with INSPIRIS and MITRIS RESILIA valves
Friday 11 Oct 2024
Minimally Invasive Surgery with the INSPIRIS RESILIA valve
MITRIS RESILIA valve:The Latest Mitral Surgical Innovation
No clinical data are available that evaluate the long-term impact of RESILIA tissue in patients. Additional clinical data for up to 10 years of follow-up are being collected to monitor the long-term safety and performance of RESILIA tissue.
Refer to device instructions for use for important warnings related to VFit technology. These features have not been observed in clinical studies to establish the safety and effectiveness of the model 11500A for use in ViV procedures. VFit technology is available on sizes 19–25 mm.
Expert opinions, advice and all other information represent contributor’s views and not necessarily those of Edwards Lifesciences.
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult https://eifu.edwards.com where applicable).